BOTH (Bioethics) Beta: -8.4556 (As of Jun. 26, 2026)


What is Bioethics Beta?

Bioethics BOTH Beta is -8.4556 as of Jun. 26, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Bioethics's Beta is -8.4556.


Bioethics  (OTCPK:BOTH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Bioethics Beta Related Terms


Bioethics Beta Historical Data

* Premium members only.

The historical data trend for Bioethics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioethics Beta Chart

Bioethics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 1.07 0.16 0.12 -3.72

Bioethics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 -2.83 -2.92 -3.72

BOTH vs NXTFF, BISA, STRG: Beta Comparison

For the Shell Companies subindustry, Bioethics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioethics Beta vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Bioethics's Beta distribution charts can be found below:

* The bar in red indicates where Bioethics's Beta falls into.



Bioethics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -8.4556 mean?
Bioethics (BOTH) has a Beta of -8.4556 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Bioethics and its competitors.
Is Bioethics' Beta too high?
Bioethics' current Beta is -8.4556.
How does Bioethics' Beta compare to NXTFF and BISA?
Bioethics' Beta of -8.4556 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Diversified Financial Services company?
A good Beta depends on the Diversified Financial Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Bioethics and its competitors. Bioethics's current Beta is -8.4556. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioethics stock overvalued right now?
Bioethics (BOTH) has a current Beta of -8.4556. The current Beta is -8.4556. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Bioethics (BOTH), the current Beta is -8.4556 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioethics Business Description

Address 1661 Lakeview Circle, Ogden, UT, USA, 84403
Bioethics Ltd is a shell company that conducts no active business operations and is seeking business opportunities for acquisition or participation by the company.